Laurion Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-35,173	Closed	-$74.6K	–	293
2023 Q3	$74.6K	Buy	35,173 +19,787	+129%	+$41.9K	﹤0.01%	218
2023 Q2	$73.2K	Buy	+15,386	New	+$73.2K	﹤0.01%	309
2022 Q2	–	Sell	-11,950	Closed	-$463K	–	424
2022 Q1	$463K	Buy	+11,950	New	+$463K	0.01%	265